317-488-5500 
Most people first suspect a new medication hurt them when something outside the doctor’s office tips them off: a pharmacy letter, a label change, a news story about a lawsuit over the pill in their cabinet. From there, a claim moves through a series of decisions made in roughly the same order every time, and a wrong turn at the first one can end a case that was otherwise sound. Christie Bell & Marshall represents Indiana patients hurt by medications, and our Indianapolis medication error lawyers can tell you which of those paths your situation is on, at no cost to you.
Why a New Drug Carries Risks Nobody Has Measured Yet
A drug reaches your pharmacy after years of testing, but the testing has a ceiling. In the final stage of human trials, a medication is typically given to 300 to 3,000 volunteers over one to four years, according to the FDA’s own description of the clinical research phase.
Compare that with what happens after launch. A popular new drug can be prescribed to more people in its first year than every trial combined, including patients who were never studied: people on five other medications, people with kidney or liver disease, older adults, pregnant women. A side effect that strikes one patient in several thousand may not show up at all in a trial and then appear in clusters once the drug is in wide use.
The agency is candid about this. In describing its post-market safety work, the FDA states that it is impossible to have complete information about a drug’s safety at the time of approval. That gap is the reason a drug can be both properly approved and dangerous, and it is where most new drug lawsuits begin. Whether yours is one of them starts with a single question.
Decision One: Was It the Drug?
Before anyone argues about warnings or defects, the claim has to survive the defense’s first move, which is to blame something else: the illness the drug was treating, another prescription, age, or bad luck. Building the answer usually takes five pieces:
- A timeline. Pharmacy fill records show the day you started, every dose change, and when you stopped. Your chart shows when symptoms first appeared. The two have to line up.
- What happened when the drug stopped. Symptoms that ease after the medication is discontinued, and return if it is restarted, are some of the strongest evidence of cause a patient can have. Doctors record this, and it matters.
- The label as it read when you took it. Current prescribing information for most U.S. drugs is published on DailyMed, run by the National Library of Medicine. The question is whether your injury was listed, listed but downplayed, or missing entirely.
- Other explanations, ruled in or out. A good case confronts the alternatives directly rather than hoping the defense misses them.
- A treating or consulting specialist. Someone qualified in the affected organ system has to be willing to say, in writing, that the drug more likely than not caused your harm.
If those pieces hold, the next question is who is responsible, and the answer is not always the company that made the pill. CBM works through this sequence with you before anything is filed.
Decision Two: A Defective Drug or a Medication Error?
The same injury can come from two very different failures, and Indiana routes them through different legal systems.
When the product itself is the problem
If the drug’s risks were known or knowable and not adequately disclosed, or the medication was contaminated or mislabeled at the plant, the claim runs against the manufacturer under the Indiana Product Liability Act. For warning and design claims, the statute asks whether the manufacturer failed to exercise reasonable care. One hurdle is specific to drugs: Indiana presumes a product was not defective if it complied with applicable federal standards, and FDA approval is the standard a drug company will point to. The presumption is rebuttable, which means evidence about what the company learned after approval, and when it changed the label, can overcome it.
When a prescriber, pharmacy, or hospital made the mistake
A doctor who prescribed a drug despite a listed contraindication, a pharmacy that filled the wrong strength, or a hospital that doubled a dose is a different case. When a physician, hospital, or other covered health care provider makes a prescription drug error, the claim falls under Indiana’s Medical Malpractice Act, and it generally cannot go to court until a medical review panel of physicians has reviewed it and issued an opinion. Damages under that act are capped by statute, while product claims against a manufacturer are not. A pharmacy’s dispensing mistake may follow a different route depending on who made it, so it is worth identifying every hand the prescription passed through.
Some injuries involve both, and the two claims can proceed side by side. Sorting them early is one of the most useful things our attorneys do in a first review.
Decision Three: Brand Name or Generic?
This question surprises nearly everyone, and it can decide whether a lawsuit exists at all.
Federal law requires a generic drug to carry the same label as the brand-name version it copies. In PLIVA v. Mensing (2011), the U.S. Supreme Court held that because generic makers cannot change that label on their own, state failure-to-warn claims against them are preempted. Two years later, in Mutual Pharmaceutical v. Bartlett, the Court extended that reasoning to design-defect claims that turn on the adequacy of a generic’s warnings.
Brand-name manufacturers stand in a different position. In Wyeth v. Levine (2009), the Court held that FDA approval of a label does not shield the brand company from a failure-to-warn claim, because federal rules let it strengthen a warning without waiting for FDA permission.
The practical point is simple. Your pharmacy records show the manufacturer of every fill, and those records should be pulled before anyone assumes which company is responsible. Because most new drugs are still under patent and sold only as brand-name products, many recent drug injuries fall on the side where product liability claims remain available. CBM checks this before advising you on anything else.
Decision Four: Your Own Case or a Federal MDL?
When many patients report the same injury from the same drug, federal cases are often gathered before a single judge through multidistrict litigation, or MDL. The Judicial Panel on Multidistrict Litigation publishes the pending list each month. Drug and pharmaceutical proceedings on its September 1, 2026 report include:
- GLP-1 receptor agonists. Two separate proceedings, one for gastrointestinal and related injuries and one for a form of optic nerve damage known as NAION.
- Depo-Provera. Claims over the injectable contraceptive.
- Suboxone film. Claims involving the buprenorphine and naloxone film.
- Tepezza. Claims involving the thyroid eye disease treatment.
- Zantac (ranitidine). The heartburn medication litigation remains on the pending list.
- National Prescription Opiate Litigation. The large consolidated opioid proceeding in Ohio.
An MDL is not a class action. Each patient files an individual case that keeps its own medical record, its own damages, and its own value; the consolidation covers shared pretrial work such as document discovery and expert challenges. Whether filing into an MDL, in Indiana state court, or waiting makes sense depends on your facts, and our team walks through that choice with you.
Decision Five: How Much Time Is Left
Deadlines are where drug cases most often die quietly, because the injury may surface long after the first dose.
- Product claims against the manufacturer. Under IC 34-20-3-1, suit generally must be filed within two years after the claim accrues and within ten years after the product was delivered to the first user. If the claim accrues between year eight and year ten, the statute still allows two years from accrual.
- Medical malpractice claims. A claim against a doctor, hospital, or other covered provider must usually be filed within two years of the negligent act itself, a clock that can run before a patient connects the dots.
- Fatal drug injuries. When a medication or a dosing error causes a death, the family’s claim moves under Indiana’s wrongful death statute, which carries its own rules on who files and when.
Two claims arising from one injury can have two different deadlines. That alone is reason to have the dates reviewed while every option is still open.
Chad J. Bradford on Medication Injury Claims
Chad J. Bradford defended doctors, nurses, and hospitals for over two decades before he began representing injured patients at CBM. Here is where he sees medication cases won or lost:
“When I was on the defense side, the first thing we looked for in a drug case was another explanation: the underlying disease, a second prescription, something in the patient’s history. So that is where I start for my clients now. Before we talk about the manufacturer or the pharmacy, we build the timeline from fill records and chart notes, and we ask a specialist the same question the other side will ask. If the timeline holds up, the case usually does. If it does not, you deserve to hear that from me early, not after two years of waiting.”
Medication and anesthesia cases can carry the highest stakes. CBM recovered $1,800,000 in a wrongful death case involving improper anesthesia care, one of the medical outcomes listed among the firm’s case results. A past result is not a promise about a future one, since no two patients, prescriptions, or injuries are alike.
Contact Christie Bell & Marshall About a Medication Injury
A new drug case rewards people who move early and keep their paperwork: the bottle and its lot number, pharmacy receipts, the patient information sheet, and the dates symptoms began. Our attorneys can pull the rest, including complete pharmacy histories, prescribing records, and the label history for the specific drug you took, then give you a plain answer about whether the case holds together and which of the paths above it belongs on.
The review is free, and CBM is paid only if we recover money for you. Contact our team to set up a confidential conversation about your medication and your injury.
FAQs About New Drug Lawsuits
How do I know if a new drug caused my injury?
Start with the timeline and the label. If your symptoms began after you started the medication, eased when you stopped it, and match a risk the drug is known or suspected to carry, that is the core of a causation case. The final answer comes from a qualified physician who reviews your records and rules out other explanations, which is why the chart and pharmacy history matter more than the news coverage.
What are some recent pharmaceutical lawsuits?
As of the Judicial Panel on Multidistrict Litigation’s September 2026 report, pending federal drug proceedings include GLP-1 receptor agonist claims (drugs in the class that includes semaglutide), Depo-Provera, Suboxone film, Tepezza, the long-running Zantac litigation, and the national opioid proceeding. Zantac also drew an earlier recall of ranitidine heartburn medications over a probable carcinogen. A pending proceeding does not mean every patient who took the drug has a claim; each case still needs its own proof of injury and causation.
What is the average payout for a class action lawsuit?
There is no meaningful average, and most drug injury cases are not class actions at all. Personal injury claims over a medication are usually individual lawsuits, sometimes grouped in an MDL, and each is valued on its own medical costs, lost income, and the severity and permanence of the harm. Where a global settlement is reached, it is often divided using a points or tier system tied to each claimant’s documented injuries, which is why careful settlement planning starts with complete records.
What’s going on with the opioid lawsuit?
The national opioid proceeding, In re National Prescription Opiate Litigation, is still listed as a pending MDL in the Northern District of Ohio as of September 2026. Most of that litigation was brought by states, counties, and cities to recover public costs, and many of the large settlements were paid to governments rather than to individual patients. People harmed by an opioid prescription often have a stronger path through a claim focused on how the drug was prescribed, dispensed, or monitored, which usually raises Indiana malpractice questions.
How long do I have to file a new drug lawsuit in Indiana?
It depends on who you are suing. Claims against a manufacturer generally must be filed within two years of accrual and within ten years of the product’s first delivery, while claims against a prescriber or other covered provider follow the Indiana medical malpractice time limits, which usually run from the date of the error. Because both can apply to one injury, have the dates checked as soon as you suspect the medication.
Call 317-488-5500 or complete a Free Case Evaluation form
